Methods for Comparison of Cost Data

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of Internal Medicine

• Publication date

  1997-10-15

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.7326/0003-4819-127-8_Part_2-199710151-00063PMID 9382393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Symptoms of Depression with Diagnostic Test Charges among Older Adults

  1997cited by this paper
• Methods for comparing the means of two independent log-normal samples.

  1997cited by this paper
• Confidence intervals for the log-normal mean .

  1997cited by this paper
• Geographic variation in resource use for coronary artery bypass surgery. IHD Port Investigators.

  1997cited by this paper
• Expenditures on services for persons with acquired immunodeficiency syndrome under a Medicaid home and community-based waiver program. Are selection effects important?

  1997cited by this paper
• Continuous Univariate Distributions.

  1995cited by this paper
• Cost of initial therapy in the Electrophysiological Study Versus ECG Monitoring trial (ESVEM).

  1995cited by this paper
• Superior Nitrogen Balance After Laparoscopic‐Assisted Colectomy

  1995cited by this paper
• A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication

  1995cited by this paper
• Medical and economic costs of psychologic distress in patients with coronary artery disease.

  1995cited by this paper
• Predicting Inpatient Costs With Admitting Clinical Data

  1995cited by this paper
• Injected-drug use: complications and costs in the care of hospitalized HIV-infected patients.

  1994cited by this paper
• Reducing Hospital Costs for the Geriatric Patient Admitted from the Emergency Department: A Randomized Trial

  1994cited by this paper
• Hospital costs of revascularization procedures for femoropopliteal arterial disease.

  1994cited by this paper
• Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease.

  1994cited by this paper
• Cost reduction in cardiac surgery.

  1994cited by this paper
• Hospital resource consumption among older adults: a prospective analysis of episodes, length of stay, and charges over a seven-year period.

  1994cited by this paper
• Pharmacoeconomic Analysis of Cefmenoxime Dual Individualization in the Treatment of Nosocomial Pneumonia

  1994cited by this paper
• Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery.

  1993cited by this paper
• Laparoscopic Cholecystectomy: Cost Analysis

  1991cited by this paper
• The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests.

  1990cited by this paper
• The Wilcoxon Test and Non‐Null Hypotheses

  1960cited by this paper

• Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing.

  2026cites this paper
• Emerging burden of post-cancer therapy complications on unplanned hospitalisation and costs among Australian cancer patients: a retrospective cohort study over 14 years

  2025cites this paper
• Mean cost and cost-effectiveness ratios with censored data: a tutorial and SAS® macros

  2025cites this paper
• Independent association of depressed mood and high suicide risk as assessed by the patient safety screener-3 (PSS-3) with prolonged hospitalization: A single-center cross-sectional study.

  2025cites this paper
• Analysis of value-based healthcare (VBHC) framework by incremental cost-effectiveness of surgical and therapeutic interventions: a retrospective study at tertiary private health group

  2025cites this paper
• Modeling Incremental Benefit of Medication Reconciliation on ICU Outcomes.

  2025cites this paper
• The Economic Burden of Atherosclerotic Cardiovascular Disease in Italy

  2024cites this paper
• Does the introduction of an infliximab biosimilar always result in savings for hospitals? A descriptive study using real-world data

  2024cites this paper
• Multicentre Analysis of Cost, Uptake and Safety of Canadian Multidisciplinary Pancreatic Cyst Guidelines

  2023cites this paper
• Study protocol of a telephone problem-solving intervention for Spanish-speaking caregivers of veterans post-stroke: an 8-session investigator-blinded, two-arm parallel (intervention vs usual care), randomized clinical trial

  2023cites this paper
• Evaluation of Web-Based and In-Person Methods to Recruit Adults With Type 1 Diabetes for a Mobile Exercise Intervention: Prospective Observational Study

  2021cites this paper
• Evaluation of Cost, Payments, Healthcare Utilization, and Perioperative and Post-Operative Outcomes of Patients Treated with Posterior Lumbar Spinal Surgery Using Open versus Minimally Invasive Surgical Approaches

  2021cites this paper
• The cost of the Acute Respiratory Distress Syndrome: A systematic review.

  2021cites this paper
• Pharmacoeconomics: Economic Evaluation of Pharmaceuticals

  2021cites this paper
• Toward collaborative cost-inclusive evaluation: Adaptations and transformations for evaluators and economists.

  2021cites this paper
• A Personalized Mobile Health Program for Type 2 Diabetes During the COVID-19 Pandemic: Single-Group Pre–Post Study

  2021cites this paper
• Postdischarge Intervention for Stroke Caregivers: Protocol for a Randomized Controlled Trial

  2020cites this paper
• Postdischarge Intervention for Stroke Caregivers: Protocol for a Randomized Controlled Trial (Preprint)

  2020cites this paper
• Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method

  2017cites this paper
• Cost‐effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis

  2017cites this paper
• Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients

  2017cites this paper
• [Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis].

  2016cites this paper
• Análisis coste-efectividad de sofosbuvir, interferón pegilado y ribavirina en pacientes con hepatitis crónica por virus C: tratamiento precoz en fases iniciales de fibrosis vs. tratamiento tardío en fases avanzadas

  2016cites this paper
• A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data

  2015cites this paper
• Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE)

  2015cites this paper
• Out-Of-Pocket Expenditures on Complementary Health Approaches Associated With Painful Health Conditions in a Nationally Representative Adult Sample.

  2015cites this paper
• Economic evaluation of web-based compared with in-person follow-up after total joint arthroplasty.

  2014cites this paper
• Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis

  2014cites this paper
• A flexible model for the mean and variance functions, with application to medical cost data

  2013cites this paper
• Incremental dementia-related expenditures in a medicaid population.

  2012cites this paper
• Use of Healthcare Services by Patients Treated with Risperidone Versus Conventional Antipsychotic Agents

  2012cites this paper
• Methods for Claims-Based Pharmacoeconomic Studies in Psychosis

  2012cites this paper
• Eptifibatide

  2012cites this paper
• [Statistical methods to control response bias in nursing activity surveys].

  2012cites this paper
• Trabectedin plus PLD versus PLD monotherapy in patients with platinum-sensitive relapsed ovarian cancer: a cost-effectiveness analysis in Spain

  2012cites this paper
• The economic cost to households of childhood malaria in Papua New Guinea: a focus on intra-country variation.

  2012cites this paper
• Median-Based Incremental Cost-Effectiveness Ratio (ICER)

  2012cites this paper
• Consciousness-Based Education: A Foundation for Teaching and Learning in the Academic Disciplines

  2011cites this paper
• Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.

  2010cites this paper
• Bayesian Confidence Intervals for the Mean of a Lognormal Distribution: A Comparison with the MOVER and Generalized Confidence Interval Procedures

  2010cites this paper
• Cost-Effectiveness of Intermittent Preventive Treatment of Malaria in Pregnancy in Southern Mozambique

  2010cites this paper
• Racial and ethnic variation in health resource use and cost for prostate cancer

  2010cites this paper
• Drug Benefits and Risks

  2010cites this paper
• Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain

  2010cites this paper
• Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers.

  2010cites this paper
• A semiparametric 2-part mixed-effects heteroscedastic transformation model for correlated right-skewed semicontinuous data.

  2009cites this paper
• Salute e Sanità

  2009cites this paper
• Krankheitskosten bei Patienten mit Kopf-, Rücken- und neuropathischen Schmerzen und Validierung der Patientenangaben anhand von Krankenkassendaten

  2009cites this paper
• Bayesian Confidence Intervals for the Ratio of Means of Lognormal Data with Zeros

  2009cites this paper
• Data-driven approach to health care : applications using claims data

  2008cites this paper
• Fall-related hospitalization and facility costs among residents of institutions providing long-term care.

  2008cites this paper
• Algorithmic Prediction of Health-Care Costs

  2008influential citation
• Is a videotape to change beliefs and behaviors superior to a standard videotape in acute low back pain? A randomized controlled trial.

  2008cites this paper
• Opt-In Medical Management Strategies

  2008cites this paper
• Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany

  2008cites this paper
• Reconsidering the impact of behavior prediction questions on illegal drug use: The importance of using proper analytic methods

  2007cites this paper
• Extensions of Two-Part Tests to Compare K Independent Populations

  2007cites this paper
• Direct Medical Cost of Influenza-Related Hospitalizations in Children

  2006cites this paper
• Cost‐effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion?

  2006cites this paper
• Cost-effectiveness as an outcome in randomized clinical trials

  2006cites this paper
• Total and Component Health Care Costs in a Non-Medicare HMO Population of Patients With and Without Type 2 Diabetes and With and Without Macrovascular Disease

  2006cites this paper
• L'évaluation des technologies de santé : les protocoles de deuxième génération

  2006cites this paper
• Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.

  2006cites this paper
• Efficient estimation of log‐normal means with application to pharmacokinetic data

  2006cites this paper
• Bootstrap Tests for Comparing the Mean Costs Between Two Health Care Strategies

  2006cites this paper
• Economic evaluation of valsartan in patients with chronic heart failure: results from Val-HeFT adapted to The Netherlands

  2006cites this paper
• COST-EFFECTIVENESS EVALUATION OF DROTRECOGIN ALFA COMPARED TO STANDARD CARE IN THE TREATMENT OF SEVERE SEPSIS IN REAL PRACTICE

  2005cites this paper
• Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorder.

  2005cites this paper
• The main methodological issues in costing health care services: A literature review

  2005cites this paper
• Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine

  2005cites this paper
• Patient Satisfaction and Use of Veterans Affairs Versus Non-Veterans Affairs Healthcare Services by Veterans

  2005cites this paper
• Regression Methods in the Empiric Analysis of Health Care Data

  2005cites this paper
• Medical cost analysis: application to colorectal cancer data from the SEER Medicare database.

  2005cites this paper
• Surgeons’ Economic Profiles: Can We Get the “Right” Answers?

  2005cites this paper
• Summary of Functional Forms Involving Logarithms for a Simple Regression Equation

  2005cites this paper
• Smooth quantile ratio estimation with regression: estimating medical expenditures for smoking-attributable diseases.

  2005cites this paper
• Smooth quantile ratio estimation

  2005cites this paper
• Medical and Pharmacy Expenditures After Implementation of a Cyclooxygenase‐2 Inhibitor Prior Authorization Program

  2005cites this paper
• Parametric modelling of cost data: some simulation evidence.

  2005cites this paper
• Medical and surgical comanagement after elective hip and knee arthroplasty: a randomized, controlled trial.

  2004cites this paper
• Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.

  2004cites this paper
• Multiple regression of cost data: use of generalised linear models

  2004cites this paper
• Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

  2004cites this paper
• Medical and Surgical Comanagement after Elective Hip and Knee Arthroplasty

  2004cites this paper
• Cost-Analysis of Relapsing-Remitting Multiple Sclerosis in Italy after the Introduction of New Disease-Modifying Agents

  2004cites this paper
• Comparing systems for costing hospital treatments. The case of stable angina pectoris.

  2004cites this paper
• Bootstrap confidence intervals for medical costs with censored observations

  2004cites this paper
• Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain.

  2004cites this paper
• Effects of smoothing on distribution approximations

  2003cites this paper
• Costs and Caregiver Consequences of Early Supported Discharge for Stroke Patients

  2003cites this paper
• [Pharmacoeconomic analyses in clinical trials. Principles and practice].

  2003cites this paper
• Inclusión de análisis farmacoeconómicos en ensayos clínicos: principios y prácticas

  2003cites this paper
• Assessing the equality of means of healthcare costs

  2003cites this paper
• Economics of One-Stage Versus Two-Stage Bilateral Total Knee Arthroplasties

  2003cites this paper
• Nonparametric regression for problems involving lognormal distributions

  2003cites this paper
• Diagnosis‐Related Group–Adjusted Hospital Costs Are Higher in Older Medical Patients with Lower Functional Status

  2003cites this paper
• Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members.

  2003cites this paper
• Cost of opioid-related adverse drug events in surgical patients.

  2003cites this paper
• The Performance of Estimation Procedures for Cost-Effectiveness Ratios

  2002cites this paper
• Worrying about normality.

  2002cites this paper